Palonosetron versus granisetron in combination with aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with gynecologic cancer

OBJECTIVE: There is no research regarding the appropriate antiemetic agents for female patients, especially those receiving moderately emetogenic chemotherapy (MEC). We evaluated the antiemetic efficacy of a combination of 5-HT(3) receptor with/without aprepitant in patients with gynecological cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujiwara, Satoe, Terai, Yoshito, Tsunetoh, Satoshi, Sasaki, Hiroshi, Kanemura, Masanori, Ohmichi, Masahide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620368/
https://www.ncbi.nlm.nih.gov/pubmed/26197776
http://dx.doi.org/10.3802/jgo.2015.26.4.311

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620368/
https://www.ncbi.nlm.nih.gov/pubmed/26197776
http://dx.doi.org/10.3802/jgo.2015.26.4.311

Ejemplares similares